Mark Woodward
The George Institute for Global Health
957 Papers
5.6K Citations
Mark Woodward is an academic researcher from The George Institute for Global Health. The author has contributed to research in topics: Medicine & Population. The author has an hindex of 133, co-authored 870 publications. Previous affiliations of Mark Woodward include New York University & University of Sydney.
Chat about Author
Papers
Prediction models for the risk of cardiovascular disease in patients with type 2 diabetes: a systematic review
S. van Dieren,Joline W.J. Beulens,Andre Pascal Kengne,Andre Pascal Kengne,Andre Pascal Kengne,L. M. Peelen,Guy E.H.M. Rutten,Mark Woodward,Y. T. van der Schouw,Karel G.M. Moons +9 more
TL;DR: Many cardiovascular risk scores are available that can be applied to patients with type 2 diabetes, but a minority of these risk scores has been validated and tested for its predictive accuracy, with only a few showing a discriminative value of ≥0.80.
214
Effects of visit-to-visit variability in systolic blood pressure on macrovascular and microvascular complications in patients with type 2 diabetes mellitus: the ADVANCE trial
Jun Hata,Hisatomi Arima,Peter M. Rothwell,Mark Woodward,Sophia Zoungas,Sophia Zoungas,Craig S. Anderson,Anushka Patel,Bruce Neal,Paul Glasziou,Pavel Hamet,Giuseppe Mancia,Neil Poulter,Bryan Williams,Stephen MacMahon,Stephen MacMahon,John Chalmers +16 more
TL;DR: Visit-to-visit variability in systolic blood pressure (SBP) and maximum SBP were independent risk factors for macrovascular and microvascular complications in type 2 diabetes mellitus.
212
ω-3 Polyunsaturated Fatty Acid Biomarkers and Coronary Heart Disease
Liana C Del Gobbo,Fumiaki Imamura,Stella Aslibekyan,Matti Marklund,Jyrki K. Virtanen,Maria Wennberg,Mohammad Yawar Yakoob,Stephanie E. Chiuve,Luicito dela Cruz,Alexis C. Frazier-Wood,Amanda M. Fretts,Eliseo Guallar,Chisa Matsumoto,Kiesha Prem,Tosh Tanaka,Jason H Y Wu,Xia Zhou,Catherine Helmer,Erik Ingelsson,Jian-Min Yuan,Pascale Barberger-Gateau,Hannia Campos,Paulo H.M. Chaves,Luc Djoussé,Graham G. Giles,Jose Gómez-Aracena,Allison M. Hodge,Frank B. Hu,Jan-Håkan Jansson,Ingegerd Johansson,Kay-Tee Khaw,Woon-Puay Koh,Rozenn N. Lemaitre,Lars Lind,Robert Luben,Eric B. Rimm,Ulf Risérus,Cécilia Samieri,Paul W. Franks,David S. Siscovick,Meir J. Stampfer,Lyn M. Steffen,Brian T. Steffen,Michael Y. Tsai,Rob M. van Dam,Sari Voutilainen,Walter C. Willett,Mark Woodward,Dariush Mozaffarian +48 more
- 27 Jun 2016
TL;DR: In continuous (per 1-SD increase) multivariable-adjusted analyses, the ω-3 biomarkers ALA, DPA, and DHA were associated with a lower risk of fatal CHD, with relative risks of 0.91, 0.84, and 0.96, respectively.
203
The impact of 2019 novel coronavirus on heart injury: A Systematic review and Meta-analysis.
TL;DR: The severity of COVID-19 is associated with acute cardiac injury, and acute cardiac injuries are associated with death, which highlights the need to effectively monitor heart health to prevent myocarditis in patients infected with CO VID-19.
203
Effect of socioeconomic group on incidence of, management of, and survival after myocardial infarction and coronary death: analysis of community coronary event register
TL;DR: Socioeconomic group affects not only death rates from myocardial infarction but also event rates and chance of admission, and allocation of resources for reduction of coronary mortality should take account of social class differences and the relative potential effect of hospital care and primary and secondary prevention.